JP2004509900A5 - - Google Patents

Download PDF

Info

Publication number
JP2004509900A5
JP2004509900A5 JP2002529123A JP2002529123A JP2004509900A5 JP 2004509900 A5 JP2004509900 A5 JP 2004509900A5 JP 2002529123 A JP2002529123 A JP 2002529123A JP 2002529123 A JP2002529123 A JP 2002529123A JP 2004509900 A5 JP2004509900 A5 JP 2004509900A5
Authority
JP
Japan
Prior art keywords
compound
compound according
alkyl
residue
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002529123A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004509900A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/029569 external-priority patent/WO2002024715A2/en
Publication of JP2004509900A publication Critical patent/JP2004509900A/ja
Publication of JP2004509900A5 publication Critical patent/JP2004509900A5/ja
Pending legal-status Critical Current

Links

JP2002529123A 2000-09-22 2001-09-21 炭水化物、脂質、またはアミノ酸キャリアを含むγ−ヒドロキシブチレート組成物 Pending JP2004509900A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23472000P 2000-09-22 2000-09-22
PCT/US2001/029569 WO2002024715A2 (en) 2000-09-22 2001-09-21 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012196299A Division JP2012246312A (ja) 2000-09-22 2012-09-06 炭水化物、脂質、またはアミノ酸キャリアを含むγ−ヒドロキシブチレート組成物

Publications (2)

Publication Number Publication Date
JP2004509900A JP2004509900A (ja) 2004-04-02
JP2004509900A5 true JP2004509900A5 (cg-RX-API-DMAC7.html) 2008-11-06

Family

ID=22882520

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002529123A Pending JP2004509900A (ja) 2000-09-22 2001-09-21 炭水化物、脂質、またはアミノ酸キャリアを含むγ−ヒドロキシブチレート組成物
JP2012196299A Pending JP2012246312A (ja) 2000-09-22 2012-09-06 炭水化物、脂質、またはアミノ酸キャリアを含むγ−ヒドロキシブチレート組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012196299A Pending JP2012246312A (ja) 2000-09-22 2012-09-06 炭水化物、脂質、またはアミノ酸キャリアを含むγ−ヒドロキシブチレート組成物

Country Status (7)

Country Link
US (4) US7015200B2 (cg-RX-API-DMAC7.html)
EP (1) EP1325014B1 (cg-RX-API-DMAC7.html)
JP (2) JP2004509900A (cg-RX-API-DMAC7.html)
AU (1) AU2001291173A1 (cg-RX-API-DMAC7.html)
CA (1) CA2423358C (cg-RX-API-DMAC7.html)
ES (1) ES2383673T3 (cg-RX-API-DMAC7.html)
WO (1) WO2002024715A2 (cg-RX-API-DMAC7.html)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10105259B2 (en) 2000-09-15 2018-10-23 Bruder Healthcare Company, Llc Wound and therapy compress and dressing
US8524973B2 (en) 2000-09-15 2013-09-03 Bruder Healthcare Company Wound and therapy compress and dressing
US9925087B2 (en) 2000-09-15 2018-03-27 Bruder Healthcare Company, Llc Wound and therapy compress and dressing
AU2001291173A1 (en) 2000-09-22 2002-04-02 Orphan Medical, Inc. Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
EP1589901A4 (en) * 2002-12-20 2006-08-09 Generipharm Inc INTRAKUTANE INJECTION
US8133881B2 (en) 2003-01-13 2012-03-13 Shire Llc Carbohydrate conjugates to prevent abuse of controlled substances
EP1594513B1 (en) * 2003-01-13 2011-08-10 Shire LLC Carbohydrate conjugates to prevent abuse of controlled substances
BRPI0515645A (pt) * 2004-09-07 2008-03-04 Orphan Medical Inc métodos terapêuticos, composições, compostos e usos de compostos
US8193211B2 (en) * 2004-09-30 2012-06-05 Supernus Pharmaceuticals, Inc. Controlled release compositions of gamma-hydroxybutyrate
KR20070085838A (ko) * 2004-11-10 2007-08-27 더 트러스티이스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 운동 장애의 치료 방법
US20120142618A1 (en) * 2007-02-13 2012-06-07 Btg International Limited Ketogenic saccharides
US8771735B2 (en) 2008-11-04 2014-07-08 Jazz Pharmaceuticals, Inc. Immediate release dosage forms of sodium oxybate
US8778398B2 (en) 2008-11-04 2014-07-15 Jazz Pharmaceuticals, Inc. Immediate release formulations and dosage forms of gamma-hydroxybutyrate
CA2759251C (en) 2009-04-23 2017-01-03 Concert Pharmaceuticals, Inc. 4-hydroxybutyric acid analogs
MX391660B (es) 2010-03-24 2025-03-21 Jazz Pharmaceuticals Inc Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas
BR112013020620A2 (pt) * 2011-02-14 2016-10-04 Concert Pharmaceuticals Inc análogos de ácido 4-hidroxibutírico
ES2774932T3 (es) 2012-11-14 2020-07-23 Cj Cheiljedang Corp Producción de sales de 4-hidroxibutirato utilizando materias primas de base biológica
US8591922B1 (en) 2012-12-14 2013-11-26 Jazz Pharmacuticals, Inc. Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US9050302B2 (en) 2013-03-01 2015-06-09 Jazz Pharmaceuticals Ireland Limited Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
WO2014143139A1 (en) 2013-03-15 2014-09-18 Bruder Healthcare Company Wound and therapy compress and dressing
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
CN108283000B (zh) 2015-09-23 2021-04-13 凯瑞康宁生物工程(武汉)有限公司 γ-羟基丁酸的前药及其组合物和用途
US12156831B2 (en) 2016-03-01 2024-12-03 The Hilsinger Company Parent, Llc Therapeutic eye compress system
US12011388B2 (en) 2016-03-01 2024-06-18 The Hilsinger Company Parent, Llc Therapeutic thermal compress with phase-change material
US12029681B2 (en) 2016-03-01 2024-07-09 The Hilsinger Company Parent, Llc Therapeutic eye mask system
US11000498B2 (en) 2016-07-22 2021-05-11 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12186296B1 (en) 2016-07-22 2025-01-07 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US12478604B1 (en) 2016-07-22 2025-11-25 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
USD871598S1 (en) 2016-11-30 2019-12-31 Bruder Healthcare Company, Llc Therapeutic eye mask
USD844795S1 (en) 2016-11-30 2019-04-02 Bruder Healthcare Company, Llc Therapeutic eye mask
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
EP3609485A4 (en) * 2017-04-11 2021-01-06 John K. Thottathil NEW PRODUCTS OF GAMMA-HYDROXYBUTYRATE (GHB) BASED ON ALPHA-HYDROXY CARBOXYLIC ACID AND DERIVATIVES AND OTHER FAT AND THEIR USES
AU2018388577B2 (en) 2017-12-18 2024-06-06 Tris Pharma, Inc. Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release
US11666546B2 (en) 2017-12-18 2023-06-06 Tris Pharma, Inc GHB pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
US12514818B2 (en) 2017-12-18 2026-01-06 Tris Pharma, Inc. Pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
US11337920B2 (en) 2017-12-18 2022-05-24 Tris Pharma, Inc. Pharmaceutical composition comprising GHB gastro-retentive raft forming systems having trigger pulse drug release
BR112021006027A2 (pt) 2018-11-19 2021-06-29 Jazz Pharmaceuticals Ireland Limited formulações de fármaco resistente a álcool
BR112021013766A2 (pt) 2019-03-01 2021-09-21 Flamel Ireland Limited Composições de gama-hidroxibutirato com farmacocinética melhorada no estado alimentado
KR20220119429A (ko) 2019-12-24 2022-08-29 재즈 파마슈티칼즈 아일랜드 리미티드 감마-히드록시부티레이트(ghb) 투약
TW202139986A (zh) 2020-02-21 2021-11-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 治療原發性嗜睡症之方法
AU2021292406B2 (en) 2020-06-18 2024-03-14 XWPharma Ltd. Controlled release granulations of water-soluble active pharmaceutical ingredients
WO2022020621A1 (en) 2020-07-24 2022-01-27 XWPharma Ltd. Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivative
AU2021357705B2 (en) 2020-10-05 2024-09-26 XWPharma Ltd. Modified release compositions of a gamma-hydroxybutyric acid derivative
US12582622B2 (en) 2020-10-08 2026-03-24 Jazz Pharmaceuticals Ireland Limited Sodium oxybate to treat idiopathic hypersomnia
AU2021362222A1 (en) 2020-10-16 2023-06-01 Jazz Pharmaceuticals Ireland Limited Treatment methods using ghb
DK4308086T3 (da) 2021-03-19 2025-11-17 Xwpharma Ltd Farmakokinetik af formuleringer med kombineret frigivelse af et gamma-hydroxysmørsyrederivat
EP4415701A1 (en) 2021-10-11 2024-08-21 Jazz Pharmaceuticals Ireland Limited Method of administering oxybate
WO2023135150A1 (en) 2022-01-11 2023-07-20 Jazz Pharmaceuticals Ireland Limited Method of administering oxybate
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
JP2025513295A (ja) * 2022-04-21 2025-04-24 ゼブラ セラピューティクス, インコーポレイテッド ガンマ-ヒドロキシブチラート送達化合物ならびにその作製および使用のためのプロセス
CN121038779A (zh) 2023-02-03 2025-11-28 特瑞斯制药公司 每晚一次的低钠羟丁酸盐组合物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2226398A1 (de) * 1972-05-31 1973-12-13 Boehringer Sohn Ingelheim Neue herzglykoside und verfahren zu ihrer herstellung
DE2702687A1 (de) * 1977-01-24 1978-07-27 Boehringer Sohn Ingelheim Neue herzglykosidderivate und verfahren zu ihrer herstellung
JPS60168044A (ja) * 1984-02-10 1985-08-31 Sharp Corp 感湿素子
US5223263A (en) 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
GB8508508D0 (en) * 1985-04-01 1985-05-09 Creighton A M Pharmaceutical compositions
US4738985A (en) * 1986-03-19 1988-04-19 The University Of Toronto Innovations Foundations Pharmaceutical composition and treatment
IT1238344B (it) * 1989-10-20 1993-07-13 Sigma Tau Ind Farmaceuti Estere della l-carnitina con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che lo contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma
IT1240760B (it) * 1990-02-12 1993-12-17 Sigma Tau Ind Farmaceuti Esteri di acil-l-carnitine con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che li contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma.
DE4026265A1 (de) 1990-08-20 1992-02-27 Boehringer Mannheim Gmbh Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel
DE4113984C2 (de) 1991-04-29 2002-05-08 Koehler Chemie Dr Franz Salze der 4-Hydroxy-Buttersäure
GB9112212D0 (en) 1991-06-06 1991-07-24 Gregoriadis Gregory Pharmaceutical compositions
IT1261485B (it) 1993-06-24 1996-05-23 Sigma Tau Ind Farmaceuti Uso di acil l-carnitine gamma-idrossibutirrato per il trattamento di tossicodipendenze.
JP2746079B2 (ja) * 1993-09-07 1998-04-28 正和薬品株式会社 血糖上昇抑制剤および脂質代謝改善剤
SE503122C2 (sv) * 1993-11-22 1996-03-25 Perstorp Ab Användning av en inositoltrisfosfatester för behandling av inflammatoriska tillstånd
SE502990C2 (sv) * 1993-11-22 1996-03-04 Perstorp Ab Användning av en inositoltrisfosfatester för beredning av ett smärtstillande läkemedel
SE502989C2 (sv) * 1993-11-22 1996-03-04 Perstorp Ab Användning av en inositoltrisfosfatester för beredning av läkemedel
CN1315473C (zh) * 1997-03-17 2007-05-16 英国技术集团国际有限公司 治疗组合物
US5990162A (en) 1997-08-29 1999-11-23 Orphan Medical, Inc. Method for treatment of fibromyalgia and chronic fatigue syndrome
AU783104B2 (en) * 1999-09-14 2005-09-22 Tepha, Inc. Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
AU2001291173A1 (en) * 2000-09-22 2002-04-02 Orphan Medical, Inc. Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
US7686215B2 (en) 2005-05-21 2010-03-30 Apple Inc. Techniques and systems for supporting podcasting
US9405855B2 (en) 2014-03-27 2016-08-02 Sap Ag Processing diff-queries on property graphs

Similar Documents

Publication Publication Date Title
TWI316942B (en) Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
CA2423358A1 (en) Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
JP2002517491A5 (cg-RX-API-DMAC7.html)
JPH1129497A5 (cg-RX-API-DMAC7.html)
JP2002525329A5 (cg-RX-API-DMAC7.html)
CN110418639B (zh) 肾上腺素前药的舌下或口含给药制剂
HUE027395T2 (hu) Eszközök nyálkahártyán keresztül történõ bejuttatására, javított felszívódással
JPH06305958A (ja) 消炎鎮痛外用貼付剤
KR20010090602A (ko) 디디에스 화합물 및 그의 측정방법
JP2008505902A5 (cg-RX-API-DMAC7.html)
US20030166513A1 (en) Dds compound and process for the preparation thereof
JP2004010479A (ja) ブロック共重合体とアンスラサイクリン系抗癌剤を含む新規固型製剤及びその製造法
BRPI0921705B1 (pt) composição farmacêutica antimicrobiana e seu uso
CN1505513A (zh) 注射用西洛他唑水性制剂
WO2015173427A2 (fr) Composition a action rapide d'insuline comprenant un compose anionique substitue et un compose polyanionique
WO2005004881A1 (en) Use of ribofuranose derivatives against inflammatory bowel diseases
CN109328058A (zh) 口腔粘膜贴附材料及其制造方法
Waldeck Some pharmacodynamic aspects on long-acting β-adrenoceptor agonists
HUE035036T2 (en) Preparation for treating mucosal inflammation due to antitumor or immunosuppressive therapy
CA2055681A1 (en) Complexes containing s(+) phenyl alkane acids and amino sugars
PT100756B (pt) Novos derivados de gangliosidos, processo para a sua preparacao e composicoes farmaceuticas que os contem
JP2005187328A (ja) イブプロフェン含有解熱鎮痛組成物、及び感冒薬
JPH08295637A (ja) 口腔部局所投与剤
WO2002083154A1 (en) Use of cationic dextran derivatives for protecting dose-limiting organs
WO2007147373B1 (en) Pharmaceutical composition for injectional, particularly targeted local administration